Cardiomyopathy Clinical Trials

A listing of Cardiomyopathy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 288 clinical trials
Magnetocardiography (MCG) Parameters in the Prediction of Future ICD Therapy (Magneto-SCD)

A multi-centre observational cohort trial to identify Magnetocardiography (MCG) parameters in the prediction of future ICD therapy. To show a correlation between Arrhythmogenic features on MCG and future ICD therapies seen on ICD interrogation of patients at risk of SCD.

Accepts healthy volunteers
  • 0 views
  • 04 Mar, 2022
  • 1 location
Routine Cardiac Screening in Sarcoidosis Patients (PAPLAND)

This protocol is an unblended randomized screening trial will have consecutive patients with no suggestion of cardiac sarcoidosis according to usual screening enroll in an enhanced screening protocol. The routine clinical care is to gather patient's history of symptoms and under go an ECG. If a patient has an abnormal …

cardiac sarcoidosis
  • 210 views
  • 15 Feb, 2022
  • 5 locations
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation

Study name: Intensive management of blood pressure and cholesterol in elderly Chinese with hypertension and atrial fibrillation (IMPRESSION) Medicine: amlodipine/atorvastatin (5/10mg tablet); amlodipine/atorvastatin (5/20mg tablet); allisartan (240mg/tablet). Rationale: controlling blood pressure and cholesterol are both effective means to reduce cardiovascular risks, however, it is still unknown whether high cardiovascular risk …

systolic blood pressure
fibrillation
antihypertensive drugs
cholesterol level
antihypertensive agents
  • 0 views
  • 18 Dec, 2021
  • 1 location
PVP-Guided Decongestive Therapy in HF (PERIPHERAL-HF)

The investigators hypothesize that a simple assessment of peripheral venous pressure (PVP) will better predict the diuretic need and long-term outcomes (all cause mortality, all cause rehospitalization, emergency department visits) compared to standard evaluation.

diuretic therapy
heart failure
chronic heart failure
  • 0 views
  • 07 Apr, 2023
  • 2 locations
Protection of Cardiac Function With Left Bundle Branch Pacing in Patients With Atrioventricular Block (OptimPacing)

OptimPacing study has been designed as a prospective, multi-center, randomized, controlled trial. A total of 11 medical centers across China will enroll 683 patients over an estimated recruitment period of 2 years. An LBBP group will be compared with a group of conventional RVP in the follow-up of at least …

  • 0 views
  • 07 Mar, 2022
  • 1 location
Arrhythmogenic Substrate in Primary Cardiomyopathies and/or Channellopathies

selected patients with primary cardiomyopathy and/or channellopaties with ICD implantation.

arrhythmia
ventricular tachycardia
cardiomyopathy
catheter ablation
idiopathic cardiomyopathy
  • 21 views
  • 08 May, 2021
  • 1 location
Ivabradine in Cirrhotic Cardiomyopathy

A total of 130 patients with liver cirrhosis who fulfill the criteria of the study, and who have been found to have left ventricular diastolic dysfunction on a screening 2D echocardiography, will then be randomized by Block randomization technique, to two arms in a ratio 1:1(Group A) will receive carvedilol+ …

cirrhosis
ivabradine
diastolic dysfunction
renal function
cardiomyopathy
  • 3 views
  • 04 Oct, 2022
  • 1 location
Pacing for Hypertrophic Obstructive Cardiomyopathy

Hypertrophic Obstructive Cardiomyopathy (HOCM) is an inherited cardiac condition which causes the heart muscle to become abnormally thick causing obstruction of blood flow in the heart. This

implantable cardioverter defibrillator
chest pain
shock
  • 0 views
  • 18 Apr, 2022
TrAstuzumab Cardiomyopathy Therapeutic Intervention With Carvedilol (TACTIC)

Breast cancer patients undergoing trastuzumab-based HER2-directed therapy are at risk of heart function decline or heart failure symptoms, but it is unknown if, when, and for how long cardiovascular protective strategies, e.g. with a beta-blocker, could help. This study randomly assigns those taking curative-intent trastuzumab-based HER2-directed therapy to the beta-blocker …

trastuzumab
pertuzumab
erbb2
her2/neu-positive breast cancer
mammogram
  • 1 views
  • 07 Oct, 2022
  • 3 locations
Prediction of Delayed Toxic Cardiomyopathy in Children (SpeckleAnthra2)

Longitudinal analysis of myocardial function using "Speckle Tracking Echocardiography" STE analysis and prediction of delayed toxic induced cardiomyopathy in young patients who received

Accepts healthy volunteers
  • 0 views
  • 08 Apr, 2023